Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FSFLD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,127
Award facts
- Contract value 100% obligated
- $18,127.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,127.20 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL units, with an ultimate completion date of September 22, 2025. This firm fixed price delivery order, awarded on September 19, 2025, utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio with the Defense Logistics Agency's Medical Supply Chain, fulfilling diverse pharmaceutical procurement needs for military and veteran healthcare systems. The company's federal awards span a wide range of therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices, with delivery orders typically structured as firm fixed price arrangements. This award of HUMIRA, a critical biologic medication for autoimmune conditions, demonstrates the company's continued role as a preferred vendor for military medical supply procurement through competitive federal contracting processes.
Quick answers
Who was awarded contract SPE2DB25FSFLD?
SPE2DB25FSFLD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FSFLD worth?
The government has obligated $18,127 on SPE2DB25FSFLD.
Is contract SPE2DB25FSFLD an order under another contract?
Yes. SPE2DB25FSFLD is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSFLD competed?
The extent of competition for SPE2DB25FSFLD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award